Till Medinger
Chairman at Antikor Biopharma Ltd.
Net worth: 1 330 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mahendra Deonarain | M | - |
Antikor Biopharma Ltd.
 Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | 23 years |
| David Traynor | M | 59 | 11 years | |
| Thomas Francis | M | 73 | 10 years | |
| Gokhan Yahioglu | M | - |
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | 23 years |
| Sean Gogarty | M | - | 5 years | |
| Hian Leng Ngiam | M | 40 |
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard William Bell | M | 73 | 8 years | |
| Stephen Brian Falder | M | 64 | 7 years | |
| John Langlands | M | 70 | 6 years | |
| Ralph Kugler | M | 68 | 5 years | |
| Gary Millar | M | 63 | 3 years | |
| Duncan Grosvenor | M | 46 | 3 years | |
| Nicholas Charles Giffard Martel | M | 63 | 4 years | |
| Denise Keenan | F | - | 8 years | |
| Nicholos Hellyer | M | 61 | 2 years | |
| Christopher Smith | M | 76 |
Helperby Therapeutics Group Ltd.
 Helperby Therapeutics Group Ltd. Miscellaneous Commercial ServicesCommercial Services Helperby Therapeutics Group Ltd. engages in the development of novel solutions to treat infectious diseases with new combinations of repurposed approved drugs. The company was founded by Anthony Milnes Coates in 2002 and is headquartered in London, the United Kingdom. | - |
| Adrian John Russell Smith | M | 79 | 5 years | |
| Wreford Wesley Devoto | M | - | - | |
| George Iain Duncan Smith | M | 70 | 1 years | |
| Elizabeth Anne Rollinson | M | - |
Antikor Biopharma Ltd.
Antikor Biopharma Ltd. BiotechnologyHealth Technology Antikor Biopharma Ltd. develops novel biologically-targeted photodynamic therapeutic agents. Its technologies include OptiLink, MRI contrast agents and imaging and Antibody-Drug Conjugates. The company was founded in 2001 by Lionel Robert Milgrom, David Phillips, Mahendra Deonarain and Gokhan Yahioglu and is headquartered in Stevenage, the United Kingdom. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 20 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Till Medinger
- Personal Network
